Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells

被引:140
作者
Berger, R
Febbo, PG
Majumder, PK
Zhao, JJ
Mukherjee, S
Signoretti, S
Campbell, KT
Sellers, WR
Roberts, TM
Loda, M
Golub, TR
Hahn, WC
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[7] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA
[8] MIT, Broad Inst, Cambridge, MA 02139 USA
[9] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
关键词
D O I
10.1158/0008-5472.CAN-04-2938
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Androgen ablation is the primary treatment modality for patients with metastatic prostate cancer; however, the role of androgen receptor signaling in prostate cancer development remains enigmatic. Using a series of genetically defined immortalized and tumorigenic human prostate epithelial cells, we found that introduction of the androgen receptor induced differentiation of transformed prostate epithelial cells to a luminal phenotype reminiscent of organ-confined prostate cancer when placed in the prostate microenvironment. Moreover, androgen receptor expression converted previously androgen-independent, tumorigenic prostate epithelial cells into cells dependent on testosterone for tumor formation. These observations indicate that androgen receptor expression is oncogenic and addictive for the human prostate epithelium.
引用
收藏
页码:8867 / 8875
页数:9
相关论文
共 62 条
  • [1] ANWAR K, 1992, CANCER RES, V52, P5991
  • [2] Androgen receptor as a target in androgen-independent prostate cancer - Discussion
    Sartor, O
    Balk, SP
    Brown, M
    [J]. UROLOGY, 2002, 60 (3A) : 138 - 139
  • [3] Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18
    Bello, D
    Webber, MM
    Kleinman, HK
    Wartinger, DD
    Rhim, JS
    [J]. CARCINOGENESIS, 1997, 18 (06) : 1215 - 1223
  • [4] Berthon P, 1997, INT J CANCER, V73, P910
  • [5] PROMOTER DELETION AND LOSS OF RETINOBLASTOMA GENE-EXPRESSION IN HUMAN PROSTATE CARCINOMA
    BOOKSTEIN, R
    RIO, P
    MADREPERLA, SA
    HONG, F
    ALLRED, C
    GRIZZLE, WE
    LEE, WH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) : 7762 - 7766
  • [6] Bright RK, 1997, CANCER RES, V57, P995
  • [7] Cairns P, 1997, CANCER RES, V57, P4997
  • [8] Molecular determinants of resistance to antiandrogen therapy
    Chen, CD
    Welsbie, DS
    Tran, C
    Baek, SH
    Chen, R
    Vessella, R
    Rosenfeld, MG
    Sawyers, CL
    [J]. NATURE MEDICINE, 2004, 10 (01) : 33 - 39
  • [9] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [10] COFFEY DS, 1981, UROLOGY, V17, P17